Register entry

CSL Behring Lengnau AG

Data as of · How to read this entry

Registered sites
0
Active NDC listings
12
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

12

12 active NDC listings: 12 plasma derivative. By marketing category: BLA 12.

Dosage formNDCs
kit12
RouteNDCs
Labeller name on the listingNDCs
csl behring lengnau ag12
Catalogue

Marketed products

12
BrandGeneric nameForm / routeNDC
AFSTYLA Antihemophilic Factor (Recombinant), Single ChainANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANTkit69911-474BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single ChainANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANTkit69911-475BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single ChainANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANTkit69911-476BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single ChainANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANTkit69911-477BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single ChainANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANTkit69911-478BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single ChainANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANTkit69911-480BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single ChainANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANTkit69911-481BLA
IDELVIONCoagulation Factor IX Recombinant Humankit69911-864BLA
IDELVIONCoagulation Factor IX Recombinant Humankit69911-865BLA
IDELVIONCoagulation Factor IX Recombinant Humankit69911-866BLA
IDELVIONCoagulation Factor IX Recombinant Humankit69911-867BLA
IDELVIONCoagulation Factor IX Recombinant Humankit69911-869BLA
Enquiry

Common questions

Is CSL Behring Lengnau AG FDA approved?
CSL Behring Lengnau AG holds no registered establishment of its own; 12 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does CSL Behring Lengnau AG make?
12 products are listed under CSL Behring Lengnau AG in the openFDA NDC Directory, most often as kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.